JENNY HANEY: Open Payments
NPI 1679015937 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,308 in 52 payments from 12 companies in 2025. Trend: 2023 $2,812 · 2024 $2,491 · 2025 $2,308
Food & beverage: $2,308
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $433 |
| E.R. Squibb & Sons, L.L.C. | 11 | $320 |
| Alkermes, Inc. | 6 | $286 |
| ABBVIE INC. | 10 | $261 |
| Axsome Therapeutics, Inc. | 3 | $252 |
| Collegium Pharmaceutical, Inc. | 2 | $214 |
| Otsuka America Pharmaceutical, Inc. | 3 | $146 |
| Lundbeck LLC | 5 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $117 |
| Tris Pharma Inc | 1 | $115 |
Products named: CAPLYTA, COBENFY, LYBALVI, REXULTI, VRAYLAR, Auvelity, Jornay PM, FANAPT.
Industry payments across TX — which companies pay providers there.
